# Abingworth Clinical Co-Development Fund 3 LP — Form D

Abingworth Clinical Co-Development Fund 3 LP of WASHINGTON, DC, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2025-06-25. Industry: Pooled Investment Fund.

## Offering

- Filed: 2025-06-25
- Form: D
- Accession: 0002049495-25-000001
- Industry: Pooled Investment Fund
- Exemptions: 06c, 3C, 3C.7
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-549752

## Issuer

- Name: Abingworth Clinical Co-Development Fund 3 LP
- CIK: 0002049495
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2025
- Address: 1001 PENNSYLVANIA AVENUE, NW, WASHINGTON, DC, 20004
- Phone: 202-729-5626

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Jeremy Anderson | Executive Officer | Washington, DC |
| Christina Gibbs | Executive Officer | Washington, DC |
| David Lobe | Executive Officer | Washington, DC |
| Robert Rosen | Executive Officer | Washington, DC |
| N/A ACCD 3 GP LP | Promoter | Washington, DC |
| N/A ACCD 3 Holdings, L.L.C. | Promoter | Washington, DC |

## More

- [CIK 2049495 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2049495&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002049495-25-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.